- Home
- HMST vs RZLT Comparison
HMST vs RZLT Comparison
Compare HMST & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMST
- RZLT
- Stock Information
- Founded
- HMST 1921
- RZLT 2010
- Country
- HMST United States
- RZLT United States
- Employees
- HMST N/A
- RZLT N/A
- Industry
- HMST Major Banks
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- HMST Finance
- RZLT Health Care
- Exchange
- HMST Nasdaq
- RZLT Nasdaq
- Market Cap
- HMST 287.6M
- RZLT 292.0M
- IPO Year
- HMST 2012
- RZLT N/A
- Fundamental
- Price
- HMST $11.95
- RZLT $5.16
- Analyst Decision
- HMST Buy
- RZLT Strong Buy
- Analyst Count
- HMST 2
- RZLT 8
- Target Price
- HMST $13.25
- RZLT $11.63
- AVG Volume (30 Days)
- HMST 215.9K
- RZLT 381.0K
- Earning Date
- HMST 01-27-2025
- RZLT 11-07-2024
- Dividend Yield
- HMST 3.38%
- RZLT N/A
- EPS Growth
- HMST N/A
- RZLT N/A
- EPS
- HMST N/A
- RZLT N/A
- Revenue
- HMST $169,710,000.00
- RZLT N/A
- Revenue This Year
- HMST N/A
- RZLT N/A
- Revenue Next Year
- HMST $12.08
- RZLT N/A
- P/E Ratio
- HMST N/A
- RZLT N/A
- Revenue Growth
- HMST N/A
- RZLT N/A
- 52 Week Low
- HMST $7.20
- RZLT $0.76
- 52 Week High
- HMST $16.10
- RZLT $6.19
- Technical
- Relative Strength Index (RSI)
- HMST 50.14
- RZLT 49.56
- Support Level
- HMST $11.25
- RZLT $4.90
- Resistance Level
- HMST $12.28
- RZLT $5.53
- Average True Range (ATR)
- HMST 0.48
- RZLT 0.39
- MACD
- HMST 0.21
- RZLT -0.00
- Stochastic Oscillator
- HMST 79.89
- RZLT 45.45
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.